ResMed is well-positioned to win in Germany’s large home care market with our strong home care provider network, vertically integrated business model, and the evolution of German digital health reimbursement models.
Hello. My name is Katherine Coconut and I'm the president of rays made in Germany. Germany is the third largest market for health care in the world. In Germany, 50 million patients are estimated to suffer from moderate to severe sleep apnea and seven million patients from COPD. This makes Germany one of the most potent markets for residents as well. In Germany we run a unique symbiotic multi channel business model. What does that mean? We are not only the leading manufacturer of products and solutions, we are also the second largest home care provider in our market, Serving over 250,000 patients directly. This business model creates the foundation for positioning resonate at the forefront of digital care solutions with the largest installed base of cloud connected patients in our market innovation. Leadership of our home care model also drive our majority market share with other home care providers solutions that aim to improve quality of care and patient experience. Our first tried and resident healthcare and then selectively offered to other home care providers, therefore enabling access to our solutions to a broader base of patient. Recent legislation in Germany that aims to accelerate the adoption of digital care solutions and apps as further expanded opportunities for residents to drive the adoption of new digital health solutions and pathways. In addition to leveraging digital technologies and patient care, we have recently launched our own digital home sleep testing services which are providing an easier and faster pathway to diagnoses for patients and helped to overcome some of the artificial barriers in our market that results from a still highly complex clinical pathway. Looking ahead resonant Germany is actively working with policymakers and PS to reimagine digitally driven therapy pathways, establish our first reimburse digital lab solutions and enable more patients access to quality diagnosis and therapy. Thank you.